LEGN
Legend Biotech Corp
NASDAQ · Healthcare · Biotechnology · US
$17.61
+0.17%0
Insider buys (3m)
2
Insider sells (3m)
-$171.1K
Net value (3m)
-39.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Zhang Ingrid · officer: Chief Executive Officer | A-Award | 1,131,860 | $0.00 |
| Aug 18, 2026 | BASH ALAN · officer: Interim CEO | A-Award | 4,908 | $0.00 |
| Jul 2, 2026 | Casey Patrick John · director | Sale | 6,000 | $15 |
| Jun 29, 2026 | Huang Ying · director, officer: Chief Executive Officer | Sale | 5,566 | $15 |
| Mar 27, 2026 | Huang Ying · director, officer: Chief Executive Officer | Sale | 9,936 | $8.77 |
Institutional positioning
13F filings over the trailing two quarters
New 93Increased 139Reduced 134Sold out 28
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 29,093,899 | Aug 13, 2026 |
| FMR LLC | Increased | 25,696,740 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Increased | 8,137,638 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Increased | 7,687,638 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 7,581,029 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Reduced | 7,070,000 | Aug 14, 2026 |
| HHLR ADVISORS, LTD. | Unchanged | 5,984,550 | Aug 14, 2026 |
| HHLR ADVISORS, LTD. | Unchanged | 5,984,550 | May 15, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | Reduced | 5,763,475 | May 11, 2026 |
| BlackRock, Inc. | Increased | 4,726,534 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 4,684,543 | May 13, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | Reduced | 4,430,063 | Aug 12, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 3,886,017 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 3,662,315 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Reduced | 3,076,124 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 16, 2026